​

Rigel Pharmaceuticals Ownership | Who Owns Rigel Pharmaceuticals?

OverviewForecastRevenueFinancialsChartTranscripts

Rigel Pharmaceuticals Ownership Summary

Rigel Pharmaceuticals is owned by 0.01% institutional investors, 2.88% insiders, and 97.11% retail investors. Barclays is the largest institutional shareholder, holding 0.01% of RIGL shares. Invesco Dorsey Wright SmallCap Momt ETF is the top mutual fund, with 6.18% of its assets in Rigel Pharmaceuticals shares.

RIGL Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockRigel Pharmaceuticals0.01%2.88%97.11%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryBiotech Stocks 68.48%9.65%21.87%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Barclays10.57K0.01%$88.00K
Farther finance advisors667.000.00%$11.22K
Nelson, van denburg & campbell wealth management group356.000.00%$5.99K
Versant capital management123.000.00%$2.07K
Ifp advisors1.00K0.00%$807.00
Eversource wealth advisors63.000.00%$1.06K
Legal & general group---
Prudential financial---
Voya investment management---
Hexagon capital partners2.00-$34.00

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Farther finance advisors667.000.00%$11.22K
Versant capital management123.000.00%$2.07K
Nelson, van denburg & campbell wealth management group356.000.00%$5.99K
Eversource wealth advisors63.000.00%$1.06K
Prudential financial---
Legal & general group---
Voya investment management---
Hexagon capital partners2.00-$34.00
National bank of canada /fi/---
Jacobs levy equity management---

Top Buyers

HolderShares% AssetsChange
Nelson, van denburg & campbell wealth management group356.000.00%356.00
Versant capital management123.000.00%123.00
Eversource wealth advisors63.000.00%-
Hexagon capital partners2.00--
Ifp advisors1.00K--

Top Sellers

HolderShares% AssetsChange
Armistice capital---15.36M
Blackrock---14.80M
Morgan stanley---14.44M
Vanguard group---9.37M
Soleus capital management---9.24M

New Positions

HolderShares% AssetsChangeValue
Versant capital management123.000.00%123.00$2.07K

Sold Out

HolderChange
Loring wolcott & coolidge fiduciary advisors llp/ma-27.00
Nisa investment advisors-432.00
Mather group, llc.-450.00
Ronald blue trust-500.00
Continuum advisory-584.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 2024650.00%1,21265.35%-39369.05%2100.00%--
Sep 30, 20244-55.56%733-94.24%-7854.79%1-50.00%--100.00%
Jun 30, 20249-92.62%12,725-99.99%-0.00%2-96.00%5-87.18%
Mar 31, 20241223.39%111,001,2854.17%631.69%50-9.09%3930.00%
Dec 31, 20231185.36%106,553,9720.27%611.65%5530.95%30-14.29%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Invesco Dorsey Wright SmallCap Momt ETF1.09M6.18%1.97K
Vanguard Total Stock Mkt Idx Inv548.78K3.07%-
Vanguard US Total Market Shares ETF548.78K3.07%-
iShares Russell 2000 ETF465.23K2.60%-4.01K
Vanguard Institutional Extnd Mkt Idx Tr265.02K1.48%432.00
SPDR® S&P Biotech ETF262.10K1.47%-2.81K
Fidelity Small Cap Index173.81K0.97%-3.25K
Delaware Healthcare I160.00K0.91%-
Macquarie Healthcare I160.00K0.90%-
Zacks Small Cap Equity Strategy133.63K0.75%5.25K

Recent Insider Transactions

DateNameRoleActivityValue
Feb 04, 2025Schorno Dean L EVP & Chief Financial OfficerSell$42.60K
Feb 05, 2025Schorno Dean L EVP & Chief Financial OfficerSell$38.02K
Feb 05, 2025Santos David A EVP, Chief Commercial OfficerSell$39.38K
Feb 04, 2025Santos David A EVP, Chief Commercial OfficerSell$44.46K
Feb 04, 2025RODRIGUEZ RAUL R CEO, PresidentSell$103.60K

Insider Transactions Trends

DateBuySell
2025 Q1-8
2024 Q4--
2024 Q3--
2024 Q2--
2024 Q1-6

RIGL Ownership FAQ

Who Owns Rigel Pharmaceuticals?

Rigel Pharmaceuticals shareholders are primarily institutional investors at 0.01%, followed by 2.88% insiders and 97.11% retail investors. The average institutional ownership in Rigel Pharmaceuticals's industry, Biotech Stocks , is 68.48%, which Rigel Pharmaceuticals falls below.

Who owns the most shares of Rigel Pharmaceuticals?

Rigel Pharmaceuticals’s largest shareholders are Barclays (10.57K shares, 0.01%), Farther finance advisors (667 shares, 0.00%), and Nelson, van denburg & campbell wealth management group (356 shares, 0.00%). Together, they hold 0.01% of Rigel Pharmaceuticals’s total shares outstanding.

Does Blackrock own Rigel Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of Rigel Pharmaceuticals.

Who is Rigel Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Farther finance advisors is Rigel Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 0.00% of its assets in 667 Rigel Pharmaceuticals shares, valued at 11.22K$.

Who is the top mutual fund holder of Rigel Pharmaceuticals shares?

Invesco Dorsey Wright SmallCap Momt ETF is the top mutual fund holder of Rigel Pharmaceuticals shares, with 6.18% of its total shares outstanding invested in 1.09M Rigel Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools